
|Articles|September 15, 2002
Itraconazole use covers various inflammatory diseases
New Orleans - Disorders that seemingly have no mycotic component could respond to a course of itraconazole (Sporanox), according to Ruggero Caputo, M.D. In fact, for certain patients, it may have a role in the treatment of inflammatory diseases such seborrheic dermatitis, atopic dermatitis, and rosacea, as well as palmo plantar amicrobic pustulosis.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
5


















